drugset / Trial / NCT03700177

Ropivacaine 0,2% Plus Dexamethasone Versus Ropivacaine 0,2% Plus Placebo in Modified Pectoral Block

NCT03700177 ↗

Phase 4 Unknown 60 enrolled Medical University Innsbruck
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To find out if dexamethasone used as adjuvant to ropivacaine, a long-lasting local anesthetic, prolongs the duration of modified pectoral nerve block in women undergoing breast surgery.

Timeline

Start
2019-02-01
Primary completion
2020-12-31
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 8 mg Other
Comparator Ropivacaine Other / unclassified 60 mg Other

Indications